XRAY officer reports 233.911 RSUs; 27,264.0691 shares held

DENTSPLY SIRONA (XRAY) executive Kevin Czerney, VP and Chief Accounting Officer, reported routine equity accruals.

Rhea-AI Filing Summary

DENTSPLY SIRONA (XRAY) executive Kevin Czerney, VP and Chief Accounting Officer, reported routine equity accruals. On 10/10/2025, he acquired 233.911 RSUs as dividend equivalents at $0, which vest on the same schedule as the underlying RSUs.

Following these transactions, his direct beneficial ownership of common stock is 27,264.0691 shares. The filing notes this includes 112.5060 shares acquired through dividend reinvestment on 10/10/2025.

He was also credited 45.4596 phantom stock units under the SERP and 4.4453 phantom stock units under the DSSP at $11.98 per unit, each economically equivalent to one common share and payable in common stock upon termination of employment.

Insider Trade Summary

Grant/Award: 283.8159 shares

Grant/Award 3 txns

Insider Czerney Kevin

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock (Supplemental Executive Retirement Plan) SERP	45.4596	$11.98	$544.61
Grant/Award	Phantom Stock (Dentsply Supplemental Savings Plan) DSSP	4.4453	$11.98	$53.25
Grant/Award	Common Stock	233.911	$0.00	$0.00

Holdings After Transaction: Phantom Stock (Supplemental Executive Retirement Plan) SERP — 3,448.3036 contracts (Direct); Phantom Stock (Dentsply Supplemental Savings Plan) DSSP — 337.1487 contracts (Direct); Common Stock — 27,264.0691 shares (Direct)

Footnotes (4)

1. F1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.
2. F2. Includes 112.5060 shares acquired through dividend reinvestment on 10/10/2025.
3. F3. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
4. F4. Comprised of phantom stock acquired as a result of accrued dividends.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did XRAY’s executive report on Form 4?

Kevin Czerney reported 233.911 RSUs as dividend equivalents and additional phantom stock units credited on 10/10/2025.

How many XRAY shares does the reporting person own after the transactions?

Direct beneficial ownership is 27,264.0691 shares of common stock.

Were there any cash purchases or sales of XRAY stock?

The RSU dividend equivalents were recorded at $0; these were accruals tied to existing awards.

What phantom stock units were credited and at what price?

SERP: 45.4596 units; DSSP: 4.4453 units, each at $11.98, economically equivalent to one share.

When do the RSU dividends and phantom stock units settle?

RSU dividends vest with the underlying RSUs. Phantom stock units are payable in common stock upon termination of employment.

Does the ownership figure include dividend reinvestment?

Yes, it includes 112.5060 shares acquired through dividend reinvestment on 10/10/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/15/2025 - 12:00 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Czerney Kevin

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/10/2025		A		233.911(1)	A	$0	27,264.0691(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(3)	10/10/2025		A		45.4596(4)		(3)	(3)	Common Stock	45.4596	$11.98	3,448.3036	D
Phantom Stock (Dentsply Supplemental Savings Plan) DSSP	(3)	10/10/2025		A		4.4453(4)		(3)	(3)	Common Stock	4.4453	$11.98	337.1487	D

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

2. Includes 112.5060 shares acquired through dividend reinvestment on 10/10/2025.

3. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.

4. Comprised of phantom stock acquired as a result of accrued dividends.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Kevin Czerney	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.